Interim Results

AI SummaryClose X

BATM Advanced Communications Limited (BATM) reported interim results for the six months ended 30 June 2025, showing revenue of $60.4 million (H1 2024: $58.9 million), a gross profit of $19.8 million (H1 2024: $18.7 million), and a gross margin of 32.7% (H1 2024: 31.7%). Adjusted operating profit was $2.0 million (H1 2024: $3.6 million), adjusted EBITDA was $4.0 million (H1 2024: $5.7 million), and adjusted profit before tax was $1.6 million (H1 2024: $3.0 million). Cash and short-term investments at 30 June 2025 were $27.0 million (31 December 2024: $31.6 million). The company highlighted a return to growth in BATM Networks and increased sales of proprietary and third-party diagnostic products in BATM Diagnostics. A key milestone was achieved in BATM Cyber with the delivery of its first encryption platform for commercial markets. Three non-core businesses were sold during the period. BATM Networks revenue increased by 11% to $6.6 million and by 156% sequentially compared with H2 2024. BATM Cyber received a new order of $1.5 million (increased to $2.1 million by period end) from a long-standing government customer. BATM Diagnostics increased revenue by 21%. The sale of Progenetics generated $2 million in consideration for BATM's 51% shareholding, and the sales of Celitron and Zer Laboratories generated approximately $383,000 in cash. The company anticipates year-on-year growth in revenue and adjusted EBITDA for the full year 2025.

Disclaimer*

UK 100

Latest directors dealings